Nuclear magnetic resonance –based co-magnetometers are essential tools for applications ranging from inertial navigation to ...

Funding to support the execution of a Phase 2 proof-of-concept trial of HER-096 in Parkinson’s disease, following completion of study ...

Elenagen plus gemcitabine improves overall survival in platinum resistant ovarian cancer without increasing toxicity in Phase ...

Nektar Therapeutics is rated Strong Buy based on promising Phase 2b maintenance data for REZPEG in atopic dermatitis. Click ...

DoD-Funded Study Accelerates Novel PTSD Mechanism into Trials; Proven Alcohol Safety Profile De-Risks Program for ...

The EFC2400 leverages nearly a decade of our experience in customer‑specific natural refrigerant systems and packages ...

Stearns and Poletti present a technically impressive study that aims to uncover a deeper understanding of microsaccade function: their role in perceptual modulation and the associated temporal ...

Applied physicists in the Harvard John A. Paulson School of Engineering and Applied Sciences (SEAS) have discovered a new way ...

EET Inside information: Herantis Pharma selected for Horizon 2025 grant of EUR 8.0 million for Phase 2 trial of HER-096 Funding to support ...

Devonian Health Group Inc. (“Devonian” or the Company) (TSXV: GSD) (OTCQB: DVHGF) today announced positive results from a follow-up preclinical study ...